The Indiana University Kelley School of Business will begin its Futurecast 2024 economic outlook tour on Nov. 1 at the downtown Indianapolis Artsgarden, presenting forecasts for the nation, Indiana and communities across the state beginning with an event in Indianapolis.
The Indiana University Melvin and Bren Simon Comprehensive Cancer Center was awarded a prestigious grant to train the next generation of cancer drug discovery and development researchers. Known as a T32 grant, the five-year, $794,000 National Cancer Institute award will establish the Pediatric and Adult Translational Cancer Drug Discovery and Development Training Program (PACT-D3).
A breast cancer researcher at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center received a five-year, $2.2 million grant from the National Cancer Institute to examine how certain immune cells support metastatic breast cancer development and how to stop it.
A new program led by Indiana University School of Medicine faculty will provide more support for mothers and babies in the Indiana Women's Prison, thanks to a new $468,000 grant from the Early Years Initiative from Early Learning Indiana.
A new partnership between the Indiana University Kelley School of Business and the Association for Financial Professionals will create new opportunities for students interested in pursuing careers in corporate finance and financial planning and analysis.
Researchers propose a new way of understanding how diseases spread between animals and humans, by focusing on the effect that agriculture, ecological and sociopolitical factors have on disease emergence and transmission.
Indiana University School of Medicine is expanding its training program for point-of-care ultrasound (POCUS) by investing in portable ultrasound systems for all students, residents, and fellows across seven specialties to use in curricula and patient care at the academic health center in Indianapolis.
Indiana University School of Medicine Department of Pathology is launching a new Division of Computational Pathology and a Research Center for Federated Learning in Precision Medicine.
Do you know what pharmacogenomics is? You might not, but you should, and all patients should.
A groundbreaking study led by experts from Indiana University School of Medicine has shed new light on the genetic underpinnings of Alzheimer's disease.
A new multi-site study led by Indiana University School of Medicine found increasing pediatric readiness in emergency departments reduces, but does not eliminate, racial and ethnic disparities in children and adolescents with acute medical emergencies.
With an uptick in COVID cases and cold and flu season approaching, health experts are warning of a possible "tripledemic". Experts from Indiana University are able to comment.
An Indiana University School of Medicine statewide project in collaboration with Indiana University Health was recently funded to support people living with dementia as well as their family care partners find more support and resources, thanks to a new $686,000 grant from the National Institute on Aging IMPACT Collaboratory.
Researchers from Indiana University School of Medicine have discovered a neglected brain region that could play a critical role in how likely a person with drug use disorders is to relapse, even after a long withdrawal period. Their findings were published recently in Biological Psychiatry.
A new study by Indiana University School of Medicine researchers uses more genetically diverse mouse models to study the accumulation and spread of abnormal tau protein deposits in the brain.
Anthony M. Newman has been appointed executive director of the Research and Education Networks Information Sharing and Analysis Center, or REN-ISAC. Based at Indiana University Bloomington, REN-ISAC helps to safeguard cybersecurity for its members organizations in US, UK, Canada, Australia, and New Zealand.
Experts from Indiana University are available to comment on a variety of topics in the worlds of politics, finance, education and disaster response making headlines the week of Aug. 14, 2023.
Patients with the genetic disorder hemophilia A receive factor VIII protein replacement treatments to replenish this clotting protein in their blood, thus preventing dangerous bleeding. Unfortunately, about 30 percent of these patients develop antibodies against the treatment and until now, despite more than 80 years of clinical experience with this complication, little has been known about its mechanism.
IU researcher Daniella Chusyd and her team are studying elephants' unique evolutionary strategies to better understand human aging — research which will also help better understand the impact human activities can have on elephant health and aging, while informing strategies and policies that allow humans and elephants to coexist.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
